Innovenn and Ateleris GmbH Announce Strategic Collaboration
MADISON, Wisc. — Innovenn, a premier boutique consultancy specializing in strategic regulatory affairs, product development, and human factors engineering for complex health technologies, today announced a strategic partnership with Ateleris GmbH, a Swiss-based leader in software engineering and applied R&D. Together, the firms will deliver advanced, data-driven, and AI-enabled solutions to accelerate safe, effective, and globally compliant innovations across pharmaceutical, medical device, and digital health markets.
This collaboration brings together Innovenn’s deep regulatory, clinical, and market access expertise with Ateleris’ capabilities in algorithm design, machine learning, optimization, and embedded software. Together, the firms will co-create novel tools and insights to support the development, launch, and oversight of regulated products—particularly in the fast-growing areas of Software as a Medical Device (SaMD), digital diagnostics, digital therapeutics, and connected health technologies.
We are excited to join forces with Ateleris to push the boundaries of what’s possible in regulated health innovation,” said Mary E. Dixon, CEO of Innovenn, Inc. “This partnership combines our deep regulatory, product development and human factors expertise with Ateleris’ advanced engineering and AI capabilities, empowering clients to bring safer, smarter, and more patient-centered solutions to market faster. Together, we are shaping a new era of transformative healthcare technologies.”
Ateleris, based in Brugg AG, Switzerland, brings a strong track record of success in applying artificial intelligence and software engineering across sectors including space, energy, and logistics. This partnership marks their first dedicated entry into the life sciences domain, supported by Innovenn’s expertise in FDA, EU, and global regulatory environments.
“Working with Innovenn allows us to bring our engineering expertise to high-impact healthcare applications,” said Laszlo Etesi, CEO and Co-Founder of Ateleris. “We look forward to applying technology where it matters by co-developing intelligent systems that improve decision-making, patient outcomes, and product development efficiency.”
The partnership will launch with pilot solutions that explore software and AI solutions for regulatory planning and submission, usability analytics, and intelligent risk mitigation for digital health products, SaMD, and other regulated health technology.
For more information, please visit our websites (www.innovenn.com and https://www.ateleris.ch/) or contact Katie Brunner at katieb@innovenn.com.
About Innovenn
Innovenn, a trusted boutique consultancy redefining how regulated health innovations reach patients, partners with global pharma, biotech, and medical device leaders to deliver breakthrough products with speed, rigor, and compassion. By integrating strategic regulatory guidance, human-centered design, and strategic evidence generation, Innovenn helps innovators turn transformative ideas into meaningful patient impact.
Founded in 2014, Innovenn, is a Madison-based consultancy specializing in regulatory strategy, product development, human factors engineering, and digital innovation for life sciences. The team has supported hundreds of projects spanning combination products, Software as a Medical Device (SaMD), and advanced therapeutics — helping clients achieve global approvals and market readiness faster. Innovenn stands apart as a preferred global partner for those seeking science-driven, patient-centered, and high-integrity product development support.
About Ateleris GmbH
Ateleris is a software engineering firm delivering IT consulting, IT project management, and software architecture and design through agile software development, algorithm engineering, and software service platform options. With a strong heritage in running applied research and development projects, along with roots in space research and a passion for technological innovation, Ateleris transforms complex data into actionable insight. They are headquartered in Brugg, Switzerland.
